These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 37238700)

  • 1. Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
    Tarawneh R
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
    Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
    Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.
    Ikonomovic MD; Mi Z; Abrahamson EE
    Ageing Res Rev; 2017 Mar; 34():51-63. PubMed ID: 27829172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
    Kazim SF; Iqbal K
    Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular pathology: Cause or effect in Alzheimer disease?
    Rius-Pérez S; Tormos AM; Pérez S; Taléns-Visconti R
    Neurologia (Engl Ed); 2018 Mar; 33(2):112-120. PubMed ID: 26385017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    Powell-Doherty RD; Abbott ARN; Nelson LA; Bertke AS
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for tau at the synapse in Alzheimer's disease pathogenesis.
    Pooler AM; Noble W; Hanger DP
    Neuropharmacology; 2014 Jan; 76 Pt A():1-8. PubMed ID: 24076336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).
    Zheng X; Lin W; Jiang Y; Lu K; Wei W; Huo Q; Cui S; Yang X; Li M; Xu N; Tang C; Song JX
    Autophagy; 2021 Nov; 17(11):3833-3847. PubMed ID: 33622188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericyte loss influences Alzheimer-like neurodegeneration in mice.
    Sagare AP; Bell RD; Zhao Z; Ma Q; Winkler EA; Ramanathan A; Zlokovic BV
    Nat Commun; 2013; 4():2932. PubMed ID: 24336108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
    Guan PP; Cao LL; Wang P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease.
    Petrella JR; Hao W; Rao A; Doraiswamy PM
    Comput Math Methods Med; 2019; 2019():6216530. PubMed ID: 30863455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Abeta and tau in Alzheimer's disease, an early interim report.
    Golde TE; Petrucelli L; Lewis J
    Exp Neurol; 2010 Jun; 223(2):252-66. PubMed ID: 19716367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of neurodegeneration in Alzheimer's disease.
    Crews L; Masliah E
    Hum Mol Genet; 2010 Apr; 19(R1):R12-20. PubMed ID: 20413653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.